STESTERIS plc
Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Revenue
- $5.9B
- 8.7% YoY
- Operating margin
- 18.6%
- 17% YoY
- EBITDA
- $1.6B
- 18% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 0.9×
- $1.4B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear171% of net incomeCash flow under 80% of net income
- Dilutive SBCClear1% of revenueOver 10% of revenue
- Payouts exceed cash flowClear36% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear39% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.5B | $5.1B | $5.5B | $5.9B | 8.7% |
| Operating income | $478M | $791M | $836M | $867M | $1.1B | 27% |
| Net income | $244M | $107M | $378M | $615M | $782M | 27% |
| Operating cash flow | $685M | $757M | $973M | $1.1B | $1.3B | 17% |
| Capex | $288M | $362M | $360M | $370M | $369M | 0.3% |
| Stock-based comp | $58M | $39M | $57M | $57M | $62M | 7.5% |
| Buybacks | $56M | $309M | $12M | $211M | $236M | 11% |
| Dividends | $163M | $183M | $201M | $220M | $242M | 10.0% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $1M · 3
- Net
- −$1M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2026 | — | — | 121 | 107 |
| FY2025 | — | — | 123 | 123 |
| FY2024 | — | — | 120 | 115 |
| FY2023 | — | — | 102 | 99 |
| FY2022 | — | — | 128 | 111 |